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Background. Adhesion molecules are known to inﬂuence postoperative organ function, they are hardly involved in the
inﬂammatory response following the ischemia-reperfusion injury. We sought to investigate the potency of small interfering
RNAs to suppress adhesion molecule expression in human pulmonary microvascular endothelial cells. Methods.H u m a nl u n g
microvascular endothelial cells were transfected with speciﬁc siRNA followed by a stimulation of the cells with an inﬂammatory
cytokine. Adhesion molecule expression was determined by FACS-analysis, and reduction of intracellular mRNA was determined
by qRT-PCR. Furthermore, the attachment of isolated neutrophils on the endothelial layer was determined after siRNA
transfection. Results. In summary, siRNA transfection signiﬁcantly decrease dt h ep e r c e n t a g ep o s i t i v ec e l l si nas i n g l ec o c k t a i l
transfection of each adhesion molecule investigated. Adhering neutrophils were diminished as well. Conclusion.s i R N Am i g h t
be a promising tool for the eﬀective suppression of adhesion molecule expression on pulmonary microvascular cells, potentially
minimizing leukocyte-endothelial depending interactions of a pulmonary allograft.
1.Introduction
Formerly used as an ultimate ratio in end-stage pulmonary
diseases, lung transplantation has become a commonly
accepted therapy with an increasing number of procedures
performed annually. Despite the considerable advantages of
perioperativemedical care, two main problemsremain unre-
solved: rejection of the graft and primary graft failure (PGF)
of the allograft deﬁned by a noncardiogenic pulmonary
oedema appearing shortly after reperfusion of the trans-
planted organ. Large clinical trials report an incidence of
between22%and 57%inpatientsreceiving alungtransplant
[1, 2]. A central factor involved in the development of PGF
seems to be the expression of adhesion molecules on the sur-
face of pulmonary endothelial cells. They represent a group
ofdiﬀerentglycoproteinsandcarbohydratesexpressedonthe
surface of a wide variety of cell types, including endothelial
cells. By interfering with receptors on the leukocytes, these
adhesion molecules allow initial contact between the leuko-
cytes and the vessel wall. Firm adhesion and transendothelial
migrationfollow, resulting ina sequestrationofleukocytesat
the endothelium and the later inﬁltration of the interstitial
space. The release of proteolytic enzymes and oxygen-free
radicals contributes to damage of the alveolar membrane,
resulting in noncardiogenic pulmonary oedema.
Furthermore, some adhesion molecules seem to be in-
volved in allograft rejection and the development of obliter-
ativebronchiolitis.Diﬀerentinvestigatorshavedemonstrated
a positive correlation between the intensity of adhesion
molecule expression on the endothelium of the allograft
vasculature and clinical and histological signs of organ
rejection [3, 4].2 Journal of Nucleic Acids
Therefore, suppression of adhesion molecule expression
on the vascular endothelium (thereby interrupting the
leukocyte-endothelial interaction) seems to be a promising
tool to improve the quality of life of allograft recipients.
However, nowadays, no commonly accepted therapeutic
possibility exists. We selected three diﬀerent adhesion
molecules as targets. E-selectin from the selectins group
modulates the initial establishment of contact and causes
rolling of the leukocytes along the vascular endothelium.
Intercellular adhesion molecule 1 and vascular adhesion
moleculebelongtotheimmunoglobulinsgroupandmediate
the ﬁxed connection between leukocytes and endothelium.
Other groups of investigators have already demonstrated
that adhesion molecules play a key role when it comes to
recruitment of leukocytes in lungs, thus modulating the
subsequent inﬂammatory reaction [5].
Using small interfering RNA (siRNA) to develop new
therapies seems to show promise. Originally identiﬁed as
an intermediate of the RNA interference pathway in the
late 1980s, siRNA has become a serious alternative in
medical research and, therefore, therapeutic application. For
practical use, the sequence of the targeted gene has to be
identiﬁed in a gene library. Analogous to the gene sequence,
double-stranded siRNA is manufactured by commercial
providers and brought in the cytoplasm by transfection.
One strand of siRNA becomes part of a ribonucleoprotein
complex called RNA-induced silencing complex (RISC).
RISC can cleave RNA sequences complementary to the
siRNA strand, thereby causing the rapid degradation of
the target mRNA. Importantly, and in contrast to longer
double-stranded RNAs, siRNAs in most cases do not induce
an interferon response leading to a general cytotoxicity
[6].
Thevisionofourworking groupconsistsofusingsiRNAs
for eﬀecting temporary suppression of endothelial adhesion
molecules in pulmonary allografts in order to reduce the
early and longer-lasting losses in functionality described
aboveaswell astheincreaseinpatientmorbidityandmortal-
ity resulting therefrom.
The aim of the present study was to evaluate the potency
of speciﬁc siRNA to block the expression of intercellular
adhesion molecule 1 (ICAM1, CD 54), the vascular cell
adhesion molecule 1 (VCAM1, CD 106), and E-selectin
(CD 62E) in cultured human pulmonary microvasculature
cells.
2.Results
2.1. Adhesion Protein Receptor Expression after TNF-α Stim-
ulation. Stimulation of HLMECs with TNF resulted in
a signiﬁcant increase in receptor expression of all three
adhesion proteins measured by FACS. Maximal expression
wasfound4hand12hpost-TNF-α stimulation for ESELE
and VCAM-1, respectively. ICAM-1 expression stayed high
between 8 and 48h (see Figure 1). Concerning all three types
of adhesion molecules, the time span of twelve hours after
stimulation ensured a high expression level of all adhesion
molecules investigated.
2.1.1. Suppression of Receptor Expression by Single siRNA
Transfection. FACS analysis showed a signiﬁcant increase of
the expression of all three adhesion proteins after HLMECs
stimulation with TNF-α (Figure 2). For ESELE expression
(Figure 2(a)), the baseline value (no TNF-α and no siRNA
application)was 7.02±4.36%compared to theTNF-αgroup
(100%). Treatment of HLMECs with ESELE speciﬁc siRNA
resulted in a signiﬁcant diminished receptor expression of
68.09 ± 3.89% (P<. 001), whereas the siSCR control
group remained at 97.68 ± 0.89%. Application of ICAM-1-
speciﬁc siRNA led to a signiﬁcant reduction of the ICAM-1
expression to only 43.80 ± 8.98% (P<. 001), and treatment
of HLMECs with VCAM-1 siRNA (Figure 2(c))w a s3 5 .65 ±
6.11% compared to TNF-α stimulated cells (P<. 001) (see
Figure 2).
2.1.2. Suppression of Receptor Expression by Application of
an siRNA Cocktail Targeting All Three Diﬀerent Adhesion
Receptors. HLMECs were transfected with the 3 siRNAs in
a similar manner as that described in the experiments shown
above. However, this was not performed individually but by
combining all 3 siRNAs into a cocktail (Figure 3).
2.1.3. qRT-PCR. In addition to the determinations of the
protein level of the adhesion receptor expressions, the eﬀects
o fs i R N At r a n s f e c t i o no nE S E L E ,I C A M - 1a n dV C A M - 1
mRNA transcript levels were analysed by qRT-PCR (Figures
4(a)–4(c)).Normalizedgeneexpressionwascalculatedbythe
ΔCt method; GAPDH was used as a reference, and group 1
(nontreated and nonstimulated) was set to the value of 1.00.
The eﬀects of siESELE, siICAM-1, and siVCAM-1 on
target protein expression were strongly reﬂected by changes
in the corresponding transcript levels. All three siRNAs
(siESELE, siICAM-1 and siVCAM-1) signiﬁcantly reduced
the levels of their corresponding target mRNA compared to
the groups treated with TNF-α only (P<. 05). In contrast,
the control groups treated with siSCR showed no reduction
in respective mRNA levels (Figure 4).
Additionally, HLMECs were transfected with the 3
diﬀerent siRNAs in a similar manner as that described
in the experiments shown above. However, this was not
performed individually, but by combining all 3 siRNAs into
ac o c k t a i l( Figure 5). The application of this siRNA cocktail
targeting all three diﬀerent adhesion receptors resulted in a
high, signiﬁcant reduction of all adhesion receptor mRNAs
(Figure 5).
2.1.4. Neutrophil Adhesion Assay. Two million PMN-
neutrophils were added to each well containing conﬂuent
layersofHLMECs,andafter1hour,theadherentneutrophils
were quantiﬁed using a CASY cell counter system (Figure 6).
On the nonactivated cell layer, only approximately 2,000
neutrophils attached. The stimulation of the HLMECs with
TNF-αledtoamorethan4-foldincrease (upto7,000–9,000)
in the number of adherent granulocytes (Figures 6(a)–6(d)).
Groups transfected with speciﬁc siRNA showed signiﬁcantly
reduced adhesion of neutrophils (P<. 05). Application
of siRNA targeting ESELE eﬀected an adhesion of onlyJournal of Nucleic Acids 3
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Figure 1: Increase of the adhesion protein receptor expressions of ESELE, ICAM-1, and VCAM-1 during the ﬁrst 24 hours after TNF-
α stimulation. The y-axis represents the percentage of the respective receptor expression, and the x-axis represents the time after TNF-α
stimulation in hours.
5,855 ± 904 PMNs. Transfection with ICAM-1 siRNA
(Figure 6(b)) resulted in a diminished adhesion of 4,824 ±
57, while transfection with VCAM-1 siRNA (Figure 6(c))
resulted in an adhesion of 6,375 ± 492. Finally, the cocktail
transfection (3 diﬀerent siRNAs) resulted in 4,325 ± 113
adherent neutrophils (Figure 6(d)).
3.Discussion
Lung transplantation carries a higher perioperative mor-
bidity than other transplant procedures [7] including more
frequentoccurrenceofprimarygraftfailure.Amongavariety
of other ﬁndings, histological examinations have shown
increased inﬁltration of leukocytes into the parenchyma,
causing damage to the graft and thus reducing graft function
[8]. In particular, the vascular endothelium seems to be the
graft component that is most vulnerable to the stimulus
exerted by ischemia [9]. Endothelial activation leads to
expression of adhesion molecules, which, in turn, exert a
considerableinﬂuenceonthe interactionbetweenleukocytes
and endothelium [10–13]. Basit et al. have demonstrated
a correlation between intercellular adhesion molecule 1
(ICAM 1) and recruitment of leukocytes within pulmonary
parenchyma [5]. Additionally, in an animal model, Levine
et al. have shown that blocking of adhesion molecules
exerts a positive inﬂuence on reperfusion-associated hyper-
permeability of transplanted lungs [14]. These ﬁndings
indicate that adhesion molecules play an essential role in
the modulation of acute as well as chronic graft rejection
reactions [15, 16], thus exerting a signiﬁcant inﬂuence on
the further development of perioperative morbidity and
mortality of transplanted patients. Therefore, suppressing
expression of adhesion molecules in pulmonary allografts in
order to maintain a high level of graft function seems to be a
very promising therapeutic approach.
To gain a systematic insight into the expression pat-
terns of adhesion molecules on pulmonary microvascular
endothelial cells, tumour necrosis factor alpha, a well-
known and highly potent cytokine, was used to stimulate
expression of adhesion molecules. We have been able to
show that various adhesion molecules from the selectin and
immunoglobulin families can be stimulated to a signiﬁcant
degree but within diﬀerent time windows (see Figure 1),
which partly diﬀers from the ﬁndings published by other
investigators [17]. This might be explained by the diﬀerent
cell types used.
In analogy to the fact that diﬀerent adhesion molecules
exert diﬀerent functions, we have been able to demonstrate,4 Journal of Nucleic Acids
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Figure 2: Eﬀects of siRNA and TNF treatment on the fraction of cells positive for ESELE, ICAM-1, and VCAM-1. The y-axis reﬂects the
respective adhesion receptor expression (in %), whereby untreated cells stimulated with TNF-α (group 2) were set to 100%. x-axis: group 1:
HLMVECs without siRNA transfection and without TNF-α stimulation; group 2: HLMVECs without siRNA transfection, but with TNF-α
stimulation; group 3: HLMVECs transfected with a receptor-speciﬁc siRNA and with TNF-α stimulation; group 4: HLMVECs transfected
with a nonspeciﬁc siRNA and with TNF-α stimulation.Each bar represents the mean ± SD of n = 3 independent experiments.
by means of our experiments, that expression of diﬀerent
adhesion molecules on human lung microvascular endothe-
lial cells reaches a maximum after diﬀerent latency periods
following applicationofthestimulus.The fact thataccording
to several authors, up to 40% ofthe pulmonary parenchymal
mass might be composed of endothelial cells underlines the
particular importance of these ﬁndings when it comes to
protecting and preserving pulmonary allografts [18].
Furthermore, we were able to show that human lung mi-
crovascular endothelial cells can in fact be eﬀectively trans-
fected using a cationic liposomal transfection medium. We
decided not to use a viral vector so as to work as closely as
possible to actual clinical applicability while at the same time
preventing the restriction of our method to a safe laboratory
environment.
In the course of practical application, however, it will not
be suﬃcient to choose a single target or a single adhesion
molecule. Instead, it will be necessary to suppress a whole
series ofadhesion molecules in orderto achieve a sustainable
eﬀect, and therefore, we have also performed what we call
“cocktail transfection.” This means that we have performed
transfection of cells with a protective medium containing a
combination of the three speciﬁc siRNA sequences against
ESELE, ICAM, and VCAM and subsequently examined
the eﬀect achieved with respect to the individual adhesion
molecules. This resulted in a highly signiﬁcant reduction of
expression of the individual adhesion molecules, as shown
b yF A C Sa n a l y s i s ,q R T - P C R ,a sw e l la sb yf u n c t i o n a la s s a y s
quantifying neutrophil adhesion. It remains to be shown, of
course, whether the results achieved in a laboratory setting
under static conditions will be conﬁrmed under dynamic
conditions in animal experiments.
The present study has demonstrated that transfection
with speciﬁc siRNA in each case achieved a signiﬁcantJournal of Nucleic Acids 5
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Figure 3: Application of the mixture of 3 diﬀerent siRNAs targeting ESELE, ICAM-1, and VCAM-1 demonstrated the practicability and
eﬃcacy of transfection of multiple siRNAs simultaneously. The y-axis reﬂects the respective adhesion receptor expression (in %), whereby
untreated cells stimulated with TNF-α (group 2) were set to 100%. x-axis: group 1: HLMECs withoutsiRNA transfection and without TNF-
α stimulation; group 2: HLMECs without siRNA transfection, but with TNF-α stimulation; group 3: HLMECs transfected with 3 diﬀerent
receptor speciﬁc siRNAs andwith TNF-α stimulation;group 4: HLMECs transfected with a nonspeciﬁc siRNA andwith TNF-α stimulation.
Each bar represents the mean ± SD of n = 3 independent experiments.
degree of suppression of the adhesion molecules examined.
To the best of our knowledge, so far, this has not been
described in the literature on lung microvascular cells.
An additional advantage is the transient character of the
liposomal transfection method. The silencing is sustained
for a period of approximately 2 weeks only ([19]a n d
internal datas), after this period, a normal vascular endothe-
lium showing regular physiological reactions is once again
available.
On the basis of both the results described above and the
knowledge of the consequences of pathological interaction
between leukocytesand endotheliumin transplanted organs,
we believe that protecting pulmonary allografts by means of
siRNA transfection may represent a promising therapy for
improving both short and long-term function of pulmonary
grafts.
4.Materialsand Methods
4.1.Primary Cells andCulturing. Humanlungmicrovascular
endothelial cells (HLMECs) and the MVECGM medium
(microvascular endothelial cell growth medium) were pur-
chased from Sciencell (Carlsbad, Calif, USA). These primary
HLMECs are isolated from human lung tissue and are char-
acterized by immunoﬂuorescent methods with antibodies to
vWF/Factor VIII and CD31 (P-CAM) and by uptake of DiI-
Ac-LDL [20]. HLMECs were cultured at 37◦Cu n d5 %C O 2,
accordingtostandardprocedures.Subculturesfromthethird
passage were used for all experiments.
4.2. Transfection Protocol. One day before siRNA transfec-
tion, 150,000HLMECs per well were cultured in gelatine-
coated 12-well plateswithout antibiotics. Afterreaching 80%6 Journal of Nucleic Acids
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Figure 4: Eﬀects of siRNA and TNF-α treatment on ESELE, ICAM-1, and VCAM-1 mRNA levels. Transcript levels were examined by real-
time RT-PCR. Each bar represents the mean ± SD of three independent experiments. Gene expression was normalized in relation to group
1, which was set to the value of 1.00. Group 1: HLMECs without siRNA transfection and without TNF-α stimulation; group 2: HLMECs
without siRNA transfection, but with TNF-α stimulation; group 3: HLMECs transfected with a receptor speciﬁc siRNA and with TNF-α
stimulation;group 4: HLMECs transfected with a nonspeciﬁc siRNA and with TNF-α stimulation.
conﬂuence, the cells were transfected with 100nM speciﬁc
siRNA targeting E-selectin (ESELE) intercellular adhesion
molecule-1 (ICAM-1) or vascular adhesion molecule-1
(VCAM-1) or a nonspeciﬁc siRNA (negative control =
scrambled siRNA, siSCR) for 2 hours in a serum-free med-
ium, followed by the replacement of the supernatants with
ECM without antibiotics. Transfections of siRNA were
carried out with cellfectin, 1ng/ml (Invitrogen, Karlsruhe,
Germany).
Twelve hours later, HLMECs were stimulated with tum-
our necrosis factor-α (TNF-α) (Immunotools, Friesoythe,
Germany). Keeping in mind the time dependent expression
curves of the three adhesion molecules the time span of 12
hours after TNF stimulation ensured a high expression level
of all three adhesion molecules.
Internal not published data showed a dose dependent
manner of maximum adhesion molecule expression. For
ESELE and ICAM-1, 2.5ng/mL TNF-α,a n df o rV C A M - 1 ,
5ng/mLTNF-α were used as described previously [21–23].
Using these concentrations the speciﬁc maximum adhesion
molecule expression was not increasable any more.
Experimental Group Setup
Negative controls: HLMECs without siRNA transfec-
tion and without TNF-α stimulation.
Positive controls: HLMECs without siRNA transfec-
tion, but with TNF-α stimulation.
siRNA groups: HLMECs transfected with a receptor
speciﬁc siRNA (or a cocktail out of three siRNA) and
with TNF-α stimulation.
Scrambled-siRNA groups: HLMECs transfected with
a nonspeciﬁc siRNA and with TNF-α stimulation.Journal of Nucleic Acids 7
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Figure 5:Eﬀects ofsiRNA andTNF-α treatment onESELE, ICAM-1, andVCAM-1 mRNA levels.Experiments andgroups were asdescribed
in Figure 4.
4.3. siRNA Sequences. Three to ﬁve diﬀerent sequences(each
targeting ICAM-1, VCAM-1, or ESELE) were designed by
using various Internet-based software tools. The sequences
(all synthesized by Qiagen GmbH, Hilden, Germany) show-
ing the highest knockdownwere chosen for all further exper-
iments. The following siRNA sequences and concentrations
were used for transfection:
ESELE:
sense: 5 -GGUUGAAUGCACCACUCAAdTdT-3 
antisense: 5 -UUGAGUGGUGCAUUCAACCdTdT-
3 
ICAM-1:
sense: 5 -GCCUCAGCACGUACCUCUAdTdT-3 
antisense: 5 -UAGAGGUACGUGCUGAGGCdTdT-
3 
VCAM-1:
sense: 5 -AAUGCAACUCUCACCUUAAdTdT-3 
antisense: 5 -UUAAGGUGAGAGUUGCAUUdTdT-
3 
siSCR (scrambled siRNA):
sense: 5 -UUCUCCGAACGUGUCACGUdTdT-3 
antisense: 5 -ACGUGACACGUUCGGAGAAdTdT-
3 
4.4. Flow Cytometry (FACS). Eight hours after stimulation
with TNF-α, the cells were stained for 1 hour at 4◦Cw i t ht h e
respective antibodies in 1,000μL PBS containing 0.5% FCS
in a 1:300 dilution for ESELE and ICAM-1 and 1:200 for
VCAM-1. Antibodies (ESELE: PE-Cy5 antihuman CD62E
(IgG1 Mouse, clone 68-5H11), ICAM-1: PE antihuman
CD54 (IgG1 Mouse, clone HA 58), and VCAM-1: FITC
antihuman CD106 (IgG1 Mouse, clone 51-10C9)) were all
purchased from BD Biosciences Pharmingen (Heidelberg,
Germany). After the staining step, the cells were washed ﬁrst
with1,000μL0.5%FCSinPBSandthenwith800μLHEPES-
BBS and detached. The cells were centrifuged at 220g and8 Journal of Nucleic Acids
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Figure 6:Eﬀects of siRNA andTNF-α treatment on binding of neutrophils to conﬂuentlayers of HLMECs. The y-axis reﬂects the respective
adhesion of neutrophils (in %), whereby untreated cells stimulated with TNF-α (group 2) were set to 100%. x-axis: group 1: HLMECs
without siRNA transfection and without TNF-α stimulation; groups 2: HLMECs without siRNA transfection, but with TNF-α stimulation;
group 3: HLMECs transfected with speciﬁc siRNAs targeting ESELE (a),ICAM-1 (b), VCAM-1 (c), or all 3 diﬀerent siRNAs simultaneously
(d) plus TNF-α stimulation; group 4: HLMECs transfected with a nonspeciﬁc siRNA and with TNF-α stimulation. Each bar represents the
mean ± SD of n = 3 independent experiments, each performed in triplicate.
ﬁxed with 2.5% paraformaldehyde in PBS. Flow cytometric
analyses (5,000 cells/measurement) were performed with a
FACScan (Becton Dickinson GmbH) and evaluated with
CellQuestPro software (Becton Dickinson GmbH).
4.5. Semi-Quantitative Real-Time PCR (qRT-PCR). Eight
hours after stimulation with TNF-α, the cells were prepared
for qRT-PCR. Total RNA from cultured HLMECs was
puriﬁed by Aurum total RNA mini kit (Bio-Rad Labora-
tories, Inc., Hercules, Calif, USA). Consecutively, 200ng
of each RNA sample was reverse transcribed by iScript
cDNA Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules,
Calif,USA),accordingtothemanufacturer’s instructions. All
primers were synthesized by Operon BiotechnologiesGmbH
(K¨ oln, Germany). qRT-PCR was performed as described
previously [24]. All qRT-PCRs contained IQ SYBR Green
Supermix(Bio-RadLaboratories,Inc.,Hercules,Calif,USA),
400nM forward and reverse primer and 2ng of cDNA in a
total volume of 15μL.
Primer Sequences
ESELE:
sense: 5 -GCCCAGAGCCTTCAGTGTACC-3 
antisense: 5 -GGAATGGCTGCACCTCACAG-3 
ICAM-1:
sense: 5 -CTTGAGGGCACCTACCTCTGTC-3 
antisense: 5 -CGGCTGCTACCACAGTGATG-3 Journal of Nucleic Acids 9
VCAM-1:
sense: 5 -ACACTTTATGTCAATGTTGCCCC-3 
antisense: 5 -GAGGCTGTAGCTCCCCGT-3 
All qRT-PCRs were performed in triplicates. Normalized
gene expression was calculated by the ΔCt method using
GAPDH as a reference.
4.6. Maximal Receptor Expression after TNF-α Stimulation.
Preliminary, not in this paper, demonstrated data showed a
dose-dependent fashion of the diﬀerent adhesion molecules,
analogous to already published cell lines. They show a
concentration of 2.5μg TNF for ESELE und ICAM and 5μg
TNF for VCAM to get a expression proﬁle which was not
increasable any more. For the siRNA cocktail,we used a TNF
concentration of 2.5μg. One hundred and ﬁfty thousand
HLMECsper well were culturedand stimulated with TNF-α.
Every 2 hours for the next 24 (or 48) hours, the expression of
ICAM-1, VCAM-1, or ESELE was measured by FACS.
4.7. Adhesion of Neutrophils to Activated HLMECs. Iso-
osmotic Percoll (GE Healthcare Bio-Science AB, Uppsala,
Sweden) was formed by adding 0.18g NaCl to 20mL Percoll.
The Percoll solution was then diluted with 0.15M NaCl to
ﬁnal concentrations of 55% and 74%; 3mL of each solution
was used to form the gradient. Human blood was diluted
1:1 with PBS, and 3mL of this solution was placed on
the top of each gradient. The gradients were centrifuged at
350g for 20 minutes; cells were collected from the interface
and washed with 6mL of EGM-2. Erythrocytes were lysed
by incubating the cells with 5mL of lysing buﬀer (8.29g/L
ammonium chloride, 1g/L potassium hydrogen carbonate,
0.037g/L Na2-EDTA-2H2O). After stimulating the endothe-
lial cells with TNF-α, the medium was removed and 2
million granulocytes in 1mL EGM-2 were added to each
well. After 1 hour, the granulocyte suspension was gently
removed, and the wells were washed with medium twice.
The adherent granulocytes were detached (Detachment Kit,
Promocell GmbH, Heidelberg, Germany), resuspended in
100μL medium and quantiﬁed using a CASY cell counter
system (Sch¨ arfe System, Reutlingen, Germany).
4.8. Statistics. T h er e s u l t sa r ee x p r e s s e da sm e a n± standard
deviation (SD). The results represent the average of three
independent experiments (each performed in triplicate).
Adhesion assay: The number of attached neutrophils on
TNF-α stimulated HLMECs was adjusted to 100% (positive
control), and the number of attached cells from the exper-
iments with speciﬁc or scrambled siRNA was calculated in
relation to the 100% of the control.
Statistical analyses were performed using the statistics
software package SPSS (SPSS Software Inc., Chicago, Ill,
USA). Diﬀerences between the groups were calculated by F-
test followed by a Post hoc test (Tukey HSD). We considered
values of P<. 05 signiﬁcant.
Abbreviations
ESELE: E-Selectin
FACS: Fluorescence-activated cell sorting
GAPDH: Glyceraldehyde-3-phosphate dehydroge-
nase
HLMVEC: Human lung microvascular endothelial
cells
ICAM: Intercellular adhesion molecule
mRNA: Messenger RNA
PGF: Primary graft failure
PMN-neutrophils: Polymorphonuclear neutrophils
qRT-PCR: Real-time quantitative reverse transcrip-
ption
RISC: RNA-induced silencing complex
RNA: Ribonucleic acid
siSCR: Small interfering scrambled
siRNA: Small interfering RNA
TNF: Tumour necrosis factor
VCAM: Vascular adhesion molecule.
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